Summary
Pfizer Inc. filed a Form 8-K on October 20, 2005, to report its financial results for the third quarter of 2005. The key information for investors is contained within the press release, which is incorporated as Exhibit 99.1 to this filing. While the 8-K itself does not detail the financial figures, it serves as the official notification of the release of this crucial quarterly performance data. Investors should refer to the press release dated October 20, 2005, for specific details on Pfizer's revenue, earnings, and other key financial metrics for the third quarter of 2005. This filing indicates the public disclosure of the company's operational and financial standing during that period, which is essential for evaluating the company's performance and making informed investment decisions.
Key Highlights
- 1Pfizer Inc. announced its third quarter 2005 financial results via a press release.
- 2The press release, dated October 20, 2005, is filed as Exhibit 99.1 to the Form 8-K.
- 3This 8-K filing serves as official notification of the Q3 2005 financial performance disclosure.
- 4Investors are directed to the press release for detailed financial information.
- 5The filing date is October 20, 2005, with the earliest event reported also being October 20, 2005.